Specifically, we uncovered that the target of HDACs is acetylated histone H3 at CEBPA promoter, and that histone H3 deacetylation by HDACs leads the transcriptional inhibition of CEBPA in NPC-derived cells. This evidence concerns the gene CEBPA and nasopharyngeal carcinoma.